From Medscape Oncology

Coverage from the

American Society of Hematology (ASH) 2024 Annual Meeting

December 07 - 10, 2024; San Diego, California | Virtual/Online

December 07 - 10, 2024 San Diego, California | Virtual/Online

Conference News

ASH 2024 Iron Overload: What Hematologists Should Know
Medscape Medical News, April 11, 2025
ASH 2024 Hemophilia A: Bleeds Plummet After Experimental Gene Therapy
Medscape Medical News, December 23, 2024
ASH 2024 Follicular Lymphoma Therapy Shows Cost-Time Trade-Offs
Medscape Medical News, December 20, 2024
ASH 2024 MCL: Post-Remission, Skip Stem Cell Transplant?
Medscape Medical News, December 19, 2024
ASH 2024 FL: Tafasitamab Plus Combo Boosts Outcomes
Medscape Medical News, December 17, 2024
ASH 2024 Upfront Therapy for ITP in Kids: New Drug a Game Changer?
Medscape Medical News, December 17, 2024
ASH 2024 Daratumumab Confirmed as SOC for AL Amyloidosis
Medscape Medical News, December 17, 2024
ASH 2024 Smoldering MM: Big Prevention Benefits With Daratumumab?
Medscape Medical News, December 16, 2024
ASH 2024 MM: Dexamethasone-Sparing Approach Helps Frail Older Adults
Medscape Medical News, December 13, 2024
ASH 2024 Acalabrutinib Combo Promising as Frontline Treatment for CLL
Medscape Medical News, December 11, 2024
ASH 2024 Do GLP-1s Lower VTE Risk in People With Type 2 Diabetes?
Medscape Medical News, December 11, 2024
ASH 2024 Vertebral Fractures and Myeloma: Link Is Questionable
Medscape Medical News, December 11, 2024
ASH 2024 POLARIX: Extended Results Confirm Standard of Care for DLBCL
Medscape Medical News, December 10, 2024

ASH 2024 Smoking Linked to More Genetic Havoc in MDS
Medscape Medical News, December 10, 2024
ASH 2024 Fertility Preservation in SCD: Women Have More Complications
Medscape Medical News, December 10, 2024
ASH 2024 Does Acalabrutinib Fit Into Frontline MCL Therapy?
Medscape Medical News, December 10, 2024
ASH 2024 Epcore NHL-1 Update: Treatment Effective Before CAR T
Medscape Medical News, December 9, 2024
ASH 2024 With Chemo, Blinatumomab Boosts DFS in Pediatric B-ALL
Medscape Medical News, December 8, 2024
ASH 2024 High-Fiber Diet Linked to Improved Stem Cell Transplant, GvHD Outcomes
Medscape Medical News, December 8, 2024
ASH 2024 IVIG Prophylaxis in Myeloma Cuts Infections, Ups Survival
Medscape Medical News, December 8, 2024
ASH 2024 Rilzabrutinib Shines in Phase 3 Trial of Tough-to-Treat ITP
Medscape Medical News, December 8, 2024
ASH 2024 24-Hour Urine Testing in Multiple Myeloma: Time to Stop?
Medscape Medical News, December 7, 2024
ASH 2024 LBCL: Bispecific Antibodies Fare Less Well in Real-World Analysis
Medscape Medical News, December 7, 2024
ASH 2024 ASH 2024: New Leukemia Txs, Fewer Blood Clots With GLP-1 Rxs
Medscape Medical News, December 2, 2024
ASH 2024 ASH 2024 Myeloma Studies: My Top 10 Picks
MDedge News, November 27, 2024

Medscape Oncology©

Perspectives

Key Studies in Acute Lymphoblastic Leukemia From ASH 2024
Bijal D. Shah, MD, MS
Key Studies in Chronic Lymphocytic Leukemia From ASH 2024
Jennifer A. Woyach, MD
Paroxysmal Nocturnal Hemoglobinuria Takeaways From ASH 2024
Jamile M. Shammo, MD
Novel Insights in Thrombotic Disorders From ASH 2024
Shruti Chaturvedi, MBBS, MSCI
DLBCL Highlights From ASH 2024
John P. Leonard, MD
Chronic Myeloid Leukemia Highlights From ASH 2024
Jorge E. Cortes, MD
ASH 2024: Impact of New CML Treatments
Lindsay A. Rein, MD
ASH 2024: The Clinical Impact of New CLL Data
Suchitra Sundaram, MD
New Directions in Anemia and Related Disorders From ASH 2024
Yelena Z. Ginzburg, MD

Popular News From ASH 2023

CAR T-Cell Therapy: Cure for Systemic Autoimmune Diseases? CD19-directed CAR T-cell therapy led to persistent complete remission in 15 patients with three distinct autoantibody-dependent autoimmune diseases.
Medscape Medical News, Dec 10, 2023
In Real World, Patients With Myeloma Have Worse Outcomes A new analysis found that patients with multiple myeloma receiving standard therapies have much worse outcomes compared with those treated in clinical trials.
Medscape Medical News, Dec 09, 2023
Sickle Cell Gene Therapy 'Truly Transformative' Patients who received lovo-cel had durable remissions and reductions in vaso-occlusive events, pain crises, and hospitalizations in the longest running gene therapy trial for sickle cell disease.
Medscape Medical News, Dec 10, 2023

Previous Coverage

All material on this website is protected by copyright, Copyright © 1994-2025 by WebMD LLC. This website also contains material copyrighted by 3rd parties.